Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

This #GivingTuesday, whatever is your first priority, your second priority has to be independent media.

2021 has been one of the most dangerous and difficult years for independent journalism that we’ve ever seen. Our democracy is facing serial existential threats including the climate emergency, vaccine apartheid amid deadly pandemic, a global crisis for biodiversity, reproductive freedoms under assault, rising authoritarianism worldwide, and corporate-funded corruption of democracy that run beneath all of this. Giving Tuesday is a critical opportunity to make sure our journalism remains funded so that we can stay focused on all your priority issues. Please contribute today to keep Common Dreams alive and growing.

Please Help This #GivingTuesday -- Though our content is free to all, less than 1% of our readers give. We’re counting on you. Please help Common Dreams end the year strong.

Members of the medical staff treat a patient in the Covid-19 intensive care unit at the United Memorial Medical Center on July 28, 2020 in Houston, Texas. (Photo: Go Nakamura/Getty Images)

Public Health Experts Fear Trump FDA's Remdesivir Approval 'Without Evidence' of Widespread Benefits Signal Likely Premature Vaccine

"What I worry about the most is an October surprise—of FDA being forced to do something it doesn't want to or science doesn't support," wrote epidemiologist Eric Feigl-Ding. 

Julia Conley

Public health experts on Saturday decried the Food and Drug Administration's "troubling" approval of a Covid-19 treatment which has not been proven to help patients who are severely ill with the disease.

The FDA expanded its emergency authorization on remdesivir on Friday evening, allowing its use for all patients who are hospitalized with Covid-19. Previously, the drug had been approved—and shown to benefit—only patients who are not ill enough to require the use of a ventilator.

FDA Commissioner Stephen Hahn claimed that "the data show that this treatment has the potential to help even more hospitalized patients who are suffering from the effects of this devastating virus," but epidemiologists and other experts pushed back. 

"No published research supports such widespread use," tweeted Eric Fiegl-Ding, a fellow at the Federation of American Scientists.

Remdesivir has been shown to improve recovery time for patients who require oxygen but not ventilation, but has not been shown to save lives in the sickest patients, according to data from the New England Journal of Medicine.

"It seems to be a pattern of approval without science, without data, without evidence," Eric Topol, vice president for research at Scripps Research in La Jolla, California, told USA Today. 

Earlier this week, Topol expressed "horror" at claims made by Hahn and President Donald Trump about the efficacy of convalescent plasma in treating the coronavirus. Hahn later apologized publicly for overstating the benefits of plasma from patients who have recovered from Covid-19.

On Friday, two public relations officials were fired from their jobs at the FDA. Both had been involved in the agency's messaging regarding plasma, and one had encouraged Hahn to apologize for his original statement about the treatment. The dismissals, as well as Trump's repeated claims that the agency is standing in the way of his reelection chances by holding back approval for treatments and vaccines, raised alarm among public health experts who fear the politicization of the FDA in the midst of the Covid-19 pandemic.

For many members of the public, Topol told USA Today, the FDA's credibility has "already been sacrificed."

As Common Dreams reported earlier this week, the White House has recently suggested that a vaccine for Covid-19 could be approved by the FDA as early as September, even though phase 3 trials—the standard randomized, controlled studies generally required before authorization. The Trump campaign reportedly refers privately to a vaccine approval by October, just ahead of the general election, as "the holy grail." 

"I hope Stephen Hahn will find his conscience and think about the greater good and greater harm his agency can cause," tweeted Feigl-Ding on Saturday. "Bending to Trump White House pressure will only harm trust in the longtime venerable institution and hurt public health for generations to come."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Omar Hangs Up After Boebert Uses Call to Double Down on 'Outright Bigotry and Hate'

"Instead of apologizing for her Islamophobic comments and fabricated lies, Rep. Boebert refused to publicly acknowledge her hurtful and dangerous comments."

Jessica Corbett ·


Win for Alabama Workers as NLRB Orders New Union Vote After Amazon's Alleged Misconduct

A union leader said the decision confirmed that "Amazon's intimidation and interference prevented workers from having a fair say in whether they wanted a union in their workplace."

Jessica Corbett ·


'For the Sake of Peace,' Anti-War Groups Demand Biden Return to Nuclear Deal With Iran

"It's time to put differences aside and return to the Iran nuclear deal," said one advocate.

Julia Conley ·


'That's for Them to Decide': UK Secretary Rebuked for Claiming Vaccine Patent Waiver Won't Be 'Helpful' to Global Poor

One U.K. lawmaker asked when the government would "start putting the need to end this pandemic in front of the financial interests of Big Pharma?"

Andrea Germanos ·


Shell Slammed for Plan to Blast South African Coastline for Oil and Gas During Whale Season

"We cannot allow climate criminals, like Shell, to plunder in the name of greed," said Greenpeace.

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo